Jul. 2 at 11:51 PM
$INMB they’re selling the warrants at 1.40 currently
INmune Bio trades near-term warrant cash for extended future overhang.
INmune Bio secured immediate cash of
$905,957 by inducing holders of April 2024 Warrants to exercise 647,112 warrants at a reduced exercise price of
$1.40 per share, down from
$1.95. This both raises equity capital and issues new common shares.
In exchange, the company extended the maturity of the remaining 50% of those warrants from June 30, 2026 to December 31, 2027. That lengthens potential future dilution tied to these instruments. The shares underlying the April 2024 Warrants are already covered by an effective registration statement, facilitating issuance or resale when exercises occur.
